Skip to main content
. 2017 Aug 30;8(46):81485–81491. doi: 10.18632/oncotarget.20594

Table 1. Clinical characteristics of patients.

With Healer 256 (51.2%) Without Healer 244 (48.8%) All 500 (100%) p-value
Men 53 (35%) 97 (65%) 150 p < 0.01*
Women 203 (58%) 147 (42%) 350
Clinical characteristics
Age (Years) Mean ± Stand Dev 64.1 ± 11.1 66.6 ± 11 65.35 ± 11.1 p = 0.01*
 Women 62.6 ± 11.6 64.3 ± 12.7 63.45 ± 12.1 p = 0.62
 Men 69.9 ± 5.7 70.1 ± 6.9 70.0 ± 6.2 p = 0.86
Weight (Kgs)Mean ± Stand Dev 69.4 ± 16.4 72.4 ± 14.2 70.9 ± 15.3 p = 0.03*
 Women 67.0 ± 13.7 67.8 ± 15.2 67.5 ± 14.5 p = 0.99
 Men 81.5 ± 10.4 81.1 ± 15.1 81.3 ± 12.3 p = 0.83
Height (m) Mean ± Stand Dev 1.64 ± 0.08 1.65 ± 0.08 1.65 ± 0.08 p = 0.23
 Women 1.62 ± 0.06 1.61 ± 0.06 1.61 ± 0.06 p = 0.06
 Men 1.73 ± 0.06 1.72 ± 0.07 1.73 ± 0.07 p = 0.22
BMI (Kgs/m2)Mean ± Stand Dev 25.95 ± 5.4 26.55 ± 4.9 26.25 ± 5.1 p = 0.17
 Women 26.1 ± 5.1 26.1 ± 5.9 26.1 ± 5.4 p = 0.67
 Men 27.1 ± 3.3 27.3 ± 4.2 27.2 ± 3.7 p = 0.74
Comorbidities
Diabetes 12 (4.7%) 17 (7%) 29 (5.8%) p = 0.27
 Women 7 (3.4%) 8 (5.4%) 15 (4.3%) p = 0.36
 Men 5 (9.4%) 9 (9.3%) 14 (9.3%) p = 0.98
Hypertension 70 (27.3%) 67 (27.5%) 137 (27.4%) p = 0.97
 Women 60 (29.5%) 40 (27.2%) 100 (28.6%) p = 0.63
 Men 10 (18.9%) 27 (27.8%) 37 (24.7%) p = 0.22
Active smokers 19 (7.4%) 22 (9%) 41 (8.2%) p = 0.52
 Women 18 (8.9%) 14 (9.5%) 32 (9.1%) p = 0.83
 Men 1 (1.9%) 8 (8.2%) 9 (6.0%) -
Cancer and systemic treatment
Breast Cancer 203 (58%) 147 (42%) 350 (70%)
 Chemotherapy 86 (42%) 54 (36.7%) 140 (40%) p = 0.24
 Hormonal Therapy 1 (0.4%) 3 (1.2%) 4 (1.1%) -
Prostate Cancer 53 (35%) 97 (65%) 150 (30%)
 Chemotherapy 1 (1.9%) 3 (3%) 4 (2.6%) -
 Hormonal Therapy 23 (43.3%) 46 (47.4%) 69 (46%) p = 0.56

Legend: Kgs, Kilograms; m, meters; BMI, Body Mass Index; *, Statistically significant result.